nChroma Bio
Develops genetic medicines using targeted in vivo delivery.
$75M ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@nchromabio · created Dec 11, 2024 (23 months old) · 111 followers
Website registeredDec 2, 2024 (23 months old)
TIMELINE · MONEY RAISED
nChroma Bio | 10 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Round | $75M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Team
JW
Jeffrey Walsh CEOJM
Jenny Marlowe CDOMB
Melissa Bonner CSONG
Noah Goodman CBO
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | ||
| Not disclosed publicly |
Investors
CCormorant Asset Management
DDCVC Bio
GGV
JJanus Henderson Investors
MMubadala Capital Ventures
OOmega Funds
SSixth Street
SSofinnova Partners
WWellington Management
WWilson Sonsini Goodrich & Rosati
Companies like nChroma Bio
MManifold Bio$40M Series A · Jun 2022
RReCode TherapeuticsSeries B+ · Oct 2023AAro Biotherapeutics$41.5M Series B+ · Nov 2023
TTubulis$360M Series B+ · Oct 2025VVyriad$25M Series B+ · Jan 2026
EEnsoma$50M Series B+ · May 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nchroma-bio (get a free API key).